scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH
· Real-Time Price · USD
5.62
0.04 (0.72%)
At close: Sep 09, 2025, 3:59 PM
5.62
0.00%
After-hours: Sep 09, 2025, 04:30 PM EDT
scPharmaceuticals Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|
| Operating Segments Revenue | 16.04M | 11.75M |
| Operating Segments Revenue Growth | +36.50% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 21.23M | 21.41M | 21.37M | 21.32M | 17.51M | 17.4M | 16.24M | 14.13M | 12.1M | 10.9M | 7.18M | 6.28M | 4.28M | 2.89M | 2.19M | 2.21M | 2.65M | 2.73M | 3.42M | 3.32M | 2.54M | 2.5M | 2.12M | 2M | 1.84M | 2.32M | 2.07M | 1.95M | 5.05M | 4.65M | 2.99M | 1.67M | 2.37M | 2.07M | 943K | 2.16M | 1.48M | 1.48M |
| Selling, General, and Administrative Revenue Growth | -0.85% | +0.15% | +0.25% | +21.77% | +0.64% | +7.11% | +14.91% | +16.86% | +11.01% | +51.84% | +14.32% | +46.69% | +47.91% | +32.04% | -0.90% | -16.53% | -3.04% | -20.23% | +3.19% | +30.82% | +1.36% | +18.35% | +5.96% | +8.54% | -20.84% | +12.01% | +6.63% | -61.48% | +8.56% | +55.45% | +79.70% | -29.87% | +14.46% | +119.94% | -56.34% | +46.39% | 0.00% | n/a |
| Research and Development Revenue | 4.1M | 4.63M | 3.15M | 3.54M | 2.68M | 2.73M | 3.34M | 3.42M | 2.93M | 2.12M | 2.33M | 3.72M | 5.14M | 4.35M | 4.53M | 3.69M | 3.81M | 4.01M | 3.75M | 5.12M | 5.14M | 4.15M | 8.32M | 4.29M | 5.5M | 6.52M | 3.15M | 3.9M | 4.86M | 4.05M | 3.72M | 3.58M | 4.14M | 2.88M | 3.02M | 3.62M | 2.61M | 2.61M |
| Research and Development Revenue Growth | -11.51% | +46.83% | -10.93% | +32.27% | -1.80% | -18.33% | -2.43% | +16.60% | +38.66% | -9.03% | -37.44% | -27.69% | +18.29% | -4.04% | +22.63% | -2.97% | -5.04% | +7.05% | -26.84% | -0.39% | +23.95% | -50.16% | +93.76% | -21.89% | -15.76% | +107.18% | -19.17% | -19.75% | +19.94% | +8.93% | +3.65% | -13.51% | +43.67% | -4.38% | -16.59% | +38.53% | 0.00% | n/a |